These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 24509833)

  • 1. More-powerful virus inhibitors from structure-based analysis of HEV71 capsid-binding molecules.
    De Colibus L; Wang X; Spyrou JAB; Kelly J; Ren J; Grimes J; Puerstinger G; Stonehouse N; Walter TS; Hu Z; Wang J; Li X; Peng W; Rowlands D; Fry EE; Rao Z; Stuart DI
    Nat Struct Mol Biol; 2014 Mar; 21(3):282-288. PubMed ID: 24509833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of enterovirus 71 (EV-71) infections by a novel antiviral peptide derived from EV-71 capsid protein VP1.
    Tan CW; Chan YF; Sim KM; Tan EL; Poh CL
    PLoS One; 2012; 7(5):e34589. PubMed ID: 22563456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rosmarinic acid exhibits broad anti-enterovirus A71 activity by inhibiting the interaction between the five-fold axis of capsid VP1 and cognate sulfated receptors.
    Hsieh CF; Jheng JR; Lin GH; Chen YL; Ho JY; Liu CJ; Hsu KY; Chen YS; Chan YF; Yu HM; Hsieh PW; Chern JH; Horng JT
    Emerg Microbes Infect; 2020 Dec; 9(1):1194-1205. PubMed ID: 32397909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro and in vivo studies of a potent capsid-binding inhibitor of enterovirus 71.
    Ho JY; Chern JH; Hsieh CF; Liu ST; Liu CJ; Wang YS; Kuo TW; Hsu SJ; Yeh TK; Shih SR; Hsieh PW; Chiu CH; Horng JT
    J Antimicrob Chemother; 2016 Jul; 71(7):1922-32. PubMed ID: 27098012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Small molecules targeting coxsackievirus A16 capsid inactivate viral particles and prevent viral binding.
    Lin CJ; Liu CH; Wang JY; Lin CC; Li YF; Richardson CD; Lin LT
    Emerg Microbes Infect; 2018 Sep; 7(1):162. PubMed ID: 30254193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design, Synthesis, and Evaluation of Novel Enterovirus 71 Inhibitors as Therapeutic Drug Leads for the Treatment of Human Hand, Foot, and Mouth Disease.
    Zhang M; Wang Y; He W; Sun Y; Guo Y; Zhong W; Gao Q; Liao M; Wang X; Cai Y; Guo Y; Rao Z
    J Med Chem; 2020 Feb; 63(3):1233-1244. PubMed ID: 31939669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The capsid binder Vapendavir and the novel protease inhibitor SG85 inhibit enterovirus 71 replication.
    Tijsma A; Franco D; Tucker S; Hilgenfeld R; Froeyen M; Leyssen P; Neyts J
    Antimicrob Agents Chemother; 2014 Nov; 58(11):6990-2. PubMed ID: 25199773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyanohydrin as an Anchoring Group for Potent and Selective Inhibitors of Enterovirus 71 3C Protease.
    Zhai Y; Zhao X; Cui Z; Wang M; Wang Y; Li L; Sun Q; Yang X; Zeng D; Liu Y; Sun Y; Lou Z; Shang L; Yin Z
    J Med Chem; 2015 Dec; 58(23):9414-20. PubMed ID: 26571192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evolutionary trajectory of the VP1 gene of human enterovirus 71 genogroup B and C viruses.
    van der Sanden S; van der Avoort H; Lemey P; Uslu G; Koopmans M
    J Gen Virol; 2010 Aug; 91(Pt 8):1949-1958. PubMed ID: 20375223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New class of early-stage enterovirus inhibitors with a novel mechanism of action.
    Ma Y; Abdelnabi R; Delang L; Froeyen M; Luyten W; Neyts J; Mirabelli C
    Antiviral Res; 2017 Nov; 147():67-74. PubMed ID: 28993161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel substituted heteroaromatic piperazine and piperidine derivatives as inhibitors of human enterovirus 71 and coxsackievirus a16.
    Zhang X; Wang H; Li Y; Cao R; Zhong W; Zheng Z; Wang G; Xiao J; Li S
    Molecules; 2013 Apr; 18(5):5059-71. PubMed ID: 23629759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A single mutation in capsid protein VP1 (Q145E) of a genogroup C4 strain of human enterovirus 71 generates a mouse-virulent phenotype.
    Zaini Z; McMinn P
    J Gen Virol; 2012 Sep; 93(Pt 9):1935-1940. PubMed ID: 22647370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the virucidal effects of rosmarinic acid against enterovirus 71 infection via in vitro and in vivo study.
    Lin WY; Yu YJ; Jinn TR
    Virol J; 2019 Jul; 16(1):94. PubMed ID: 31366366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and structure-activity relationship of α-keto amides as enterovirus 71 3C protease inhibitors.
    Zeng D; Ma Y; Zhang R; Nie Q; Cui Z; Wang Y; Shang L; Yin Z
    Bioorg Med Chem Lett; 2016 Apr; 26(7):1762-6. PubMed ID: 26916437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of antiviral agents toward enterovirus 71 infection.
    Pourianfar HR; Grollo L
    J Microbiol Immunol Infect; 2015 Feb; 48(1):1-8. PubMed ID: 24560700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Suramin Derivative NF449 Interacts with the 5-fold Vertex of the Enterovirus A71 Capsid to Prevent Virus Attachment to PSGL-1 and Heparan Sulfate.
    Nishimura Y; McLaughlin NP; Pan J; Goldstein S; Hafenstein S; Shimizu H; Winkler JD; Bergelson JM
    PLoS Pathog; 2015 Oct; 11(10):e1005184. PubMed ID: 26430888
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure of human enterovirus 71 in complex with a capsid-binding inhibitor.
    Plevka P; Perera R; Yap ML; Cardosa J; Kuhn RJ; Rossmann MG
    Proc Natl Acad Sci U S A; 2013 Apr; 110(14):5463-7. PubMed ID: 23509286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mouse adaptation of a sub-genogroup B5 strain of human enterovirus 71 is associated with a novel lysine to glutamic acid substitution at position 244 in protein VP1.
    Zaini Z; Phuektes P; McMinn P
    Virus Res; 2012 Jul; 167(1):86-96. PubMed ID: 22575826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Viral engagement with host receptors blocked by a novel class of tryptophan dendrimers that targets the 5-fold-axis of the enterovirus-A71 capsid.
    Sun L; Lee H; Thibaut HJ; Lanko K; Rivero-Buceta E; Bator C; Martinez-Gualda B; Dallmeier K; Delang L; Leyssen P; Gago F; San-Félix A; Hafenstein S; Mirabelli C; Neyts J
    PLoS Pathog; 2019 May; 15(5):e1007760. PubMed ID: 31071193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The efficacy of viral capsid inhibitors in human enterovirus infection and associated diseases.
    Li C; Wang H; Shih SR; Chen TC; Li ML
    Curr Med Chem; 2007; 14(8):847-56. PubMed ID: 17430140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.